CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms
2015 · Cancer Cell · 151 citations
https://doi.org/10.1016/j.ccell.2015.06.006
M
Masato Murakami
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
427
Papers
9.6K
Citations
49
h-index
142
i10-index
Masato Murakami is an academic researcher from Japan Radioisotope Association. The author has contributed to research in topics: Physics of Superconductivity and Magnetism & Cardiac Arrhythmias and Treatments & Cardiac electrophysiology and arrhythmias. The author has an h-index of 49, co-authored 363 publications.
ORCID: 0000-0003-0716-1707Papers by this author
worksPrimary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci
2013 · Nature Communications · 124 citations
https://doi.org/10.1038/ncomms2856
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
2015 · Arthritis Research & Therapy · 48 citations
https://doi.org/10.1186/s13075-015-0718-y
Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression
2022 · PLoS ONE · 22 citations
https://doi.org/10.1371/journal.pone.0267027
The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts
2015 · Blood · 11 citations
https://doi.org/10.1182/blood.v126.23.797.797
Rare Complications of Pseudoaneurysms of the Superior Vena Cava After Transvenous Lead Extraction
2022 · JACC Case Reports · 7 citations
https://doi.org/10.1016/j.jaccas.2022.03.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat